Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
2.080
+0.030 (1.46%)
At close: Dec 20, 2024, 4:00 PM
2.100
+0.020 (0.96%)
After-hours: Dec 20, 2024, 5:35 PM EST
Rockwell Medical Market Cap
Rockwell Medical has a market cap or net worth of $67.22 million as of December 20, 2024. Its market cap has increased by 43.03% in one year.
Market Cap
67.22M
Enterprise Value
63.13M
1-Year Change
43.03%
Ranking
Category
Stock Price
$2.08
Market Cap Chart
Since December 1, 1998, Rockwell Medical's market cap has increased from $7.80M to $67.22M, an increase of 761.83%. That is a compound annual growth rate of 8.61%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 67.20M | 24.91% |
Dec 29, 2023 | 53.80M | 355.93% |
Dec 30, 2022 | 11.80M | -69.35% |
Dec 31, 2021 | 38.50M | -59.26% |
Dec 31, 2020 | 94.50M | -39.46% |
Dec 31, 2019 | 156.10M | 21.20% |
Dec 31, 2018 | 128.80M | -57.24% |
Dec 29, 2017 | 301.20M | -10.76% |
Dec 30, 2016 | 337.50M | -35.47% |
Dec 31, 2015 | 523.00M | 16.69% |
Dec 31, 2014 | 448.20M | 7.33% |
Dec 31, 2013 | 417.60M | 143.50% |
Dec 31, 2012 | 171.50M | 8.48% |
Dec 30, 2011 | 158.10M | 14.57% |
Dec 31, 2010 | 138.00M | 5.18% |
Dec 31, 2009 | 131.20M | 126.21% |
Dec 31, 2008 | 58.00M | -30.54% |
Dec 31, 2007 | 83.50M | 2.08% |
Dec 29, 2006 | 81.80M | 108.14% |
Dec 30, 2005 | 39.30M | 46.10% |
Dec 31, 2004 | 26.90M | -20.88% |
Dec 31, 2003 | 34.00M | 608.33% |
Dec 31, 2002 | 4.80M | -47.25% |
Dec 31, 2001 | 9.10M | 152.78% |
Dec 29, 2000 | 3.60M | -73.91% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Hyperfine | 67.84M |
Vigil Neuroscience | 67.78M |
P3 Health Partners | 67.60M |
908 Devices | 67.56M |
Prenetics Global | 66.90M |
PDS Biotechnology | 65.47M |
Agenus | 64.75M |
Cue Biopharma | 64.62M |